These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 9518585)
1. Effects of repeated administration of l-DOPA and apomorphine on circling behavior and striatal dopamine formation. Brannan T; Prikhojan A; Yahr MD Brain Res; 1998 Feb; 784(1-2):148-53. PubMed ID: 9518585 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA. Tomiyama M; Kimura T; Maeda T; Tanaka H; Kannari K; Baba M Synapse; 2004 Jun; 52(3):218-22. PubMed ID: 15065221 [TBL] [Abstract][Full Text] [Related]
3. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296 [TBL] [Abstract][Full Text] [Related]
4. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study. Gnanalingham KK; Robertson RG Brain Res; 1994 Mar; 640(1-2):185-94. PubMed ID: 8004447 [TBL] [Abstract][Full Text] [Related]
5. Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions. Datla KP; Blunt SB; Dexter DT Mov Disord; 2001 May; 16(3):424-34. PubMed ID: 11391735 [TBL] [Abstract][Full Text] [Related]
6. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats. Treseder SA; Rose S; Jenner P Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014 [TBL] [Abstract][Full Text] [Related]
7. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa. Saligaut C; Daoust M; Moore N; Boismare F Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513 [TBL] [Abstract][Full Text] [Related]
8. Elevated striatal dopamine levels following administration of D-DOPA and its alpha-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat. Brannan T; Prikhojan A; Yahr MD Brain Res; 1996 Apr; 718(1-2):165-8. PubMed ID: 8773780 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of acute or chronic administration of levodopa to 6-hydroxydopamine-lesioned rats on the expression of glutamic acid decarboxylase in the neostriatum and GABAA receptors subunits in the substantia nigra, pars reticulata. Katz J; Nielsen KM; Soghomonian JJ Neuroscience; 2005; 132(3):833-42. PubMed ID: 15837143 [TBL] [Abstract][Full Text] [Related]
10. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Hefti F; Melamed E; Sahakian BJ; Wurtman RJ Pharmacol Biochem Behav; 1980 Feb; 12(2):185-8. PubMed ID: 7189592 [TBL] [Abstract][Full Text] [Related]
11. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol. Xu D; Karain B; Brantley E; Shi WX J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359 [TBL] [Abstract][Full Text] [Related]
12. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats. Ciesielska A; Sharma N; Beyer J; Forsayeth J; Bankiewicz K PLoS One; 2015; 10(4):e0122708. PubMed ID: 25860990 [TBL] [Abstract][Full Text] [Related]
14. Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal lesions. Khan SM; Smith TS; Bennett JP J Neurosci Res; 1999 Jan; 55(1):71-9. PubMed ID: 9890435 [TBL] [Abstract][Full Text] [Related]
15. Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra. Konieczny J; Czarnecka A; Lenda T; Kamińska K; Lorenc-Koci E Behav Brain Res; 2014 Mar; 261():79-88. PubMed ID: 24361083 [TBL] [Abstract][Full Text] [Related]
16. Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance. Metz GA; Whishaw IQ Neuroscience; 2002; 111(2):325-36. PubMed ID: 11983318 [TBL] [Abstract][Full Text] [Related]
17. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Costall B; Marsden CD; Naylor RJ; Pycock CJ Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957 [TBL] [Abstract][Full Text] [Related]
18. 3-O-methyl-DOPA is not involved in the development of behavioral supersensitivity after repeated L-dopa administration in 6-OHDA lesioned rats. Bräutigam K; Sohr R; Morgenstern R Behav Brain Res; 1994 Jul; 63(1):41-5. PubMed ID: 7945976 [TBL] [Abstract][Full Text] [Related]
19. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions. Kääriäinen TM; García-Horsman JA; Piltonen M; Huotari M; Männistö PT Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898 [TBL] [Abstract][Full Text] [Related]
20. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa. Blunt SB; Jenner P; Marsden CD Exp Brain Res; 1992; 88(2):326-40. PubMed ID: 1577107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]